An A627V-activating mutation in the thyroid-stimulating hormone receptor gene in familial nonautoimmune hyperthyroidism
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Nonautoimmune hyperthyroidism is a very rare cause of congenital hyperthyroidism that is usually caused by an activating mutation in the thyroid-stimulating hormone receptor (TSHR) gene. In this report, we describe a case of nonautoimmune hyperthyroidism in a patient with TSHR mutation. Our patient was the younger of a set of twins born at 36 weeks and 6 days of gestation. The patient was noted to be more irritable than the older twin at 80 days of age, and the mother was taking methimazole for Graves’ disease that had been diagnosed 12 years prior. Therefore, a thyroid function test was conducted for the patient. The results revealed subclinical hyperthyroidism, and tests of antithyroglobulin antibody, antithyroid peroxidase antibody, and anti-thyroid-stimulating hormone (TSH) receptor antibody were all negative. During follow-up, at around 4 months of age, free T4 increased to 2.89 ng/dL, and TSH was still low at 0.01 μIU/mL; therefore, 3 mg/day of methimazole was initiated. Whole-exome sequencing showed a heterozygous variant of c.1800C>T (p.Ala627Val) in the TSHR gene. Testing in the family confirmed an identical variant in the patient's mother, leading to diagnosis of familial nonautoimmune hyperthyroidism inherited in an autosomal dominant pattern. This is the second report of A627V confirmed as a germline variant.
Abstract
Nonautoimmune hyperthyroidism is a very rare cause of congenital hyperthyroidism that is usually caused by an activating mutation in the thyroid-stimulating hormone receptor (TSHR) gene. In this report, we describe a case of nonautoimmune hyperthyroidism in a patient with TSHR mutation. Our patient was the younger of a set of twins born at 36 weeks and 6 days of gestation. The patient was noted to be more irritable than the older twin at 80 days of age, and the mother was taking methimazole for Graves’ disease that had been diagnosed 12 years prior. Therefore, a thyroid function test was conducted for the patient. The results revealed subclinical hyperthyroidism, and tests of antithyroglobulin antibody, antithyroid peroxidase antibody, and anti-thyroid-stimulating hormone (TSH) receptor antibody were all negative. During follow-up, at around 4 months of age, free T4 increased to 2.89 ng/dL, and TSH was still low at 0.01 μIU/mL; therefore, 3 mg/day of methimazole was initiated. Whole-exome sequencing showed a heterozygous variant of c.1800C>T (p.Ala627Val) in the TSHR gene. Testing in the family confirmed an identical variant in the patient's mother, leading to diagnosis of familial nonautoimmune hyperthyroidism inherited in an autosomal dominant pattern. This is the second report of A627V confirmed as a germline variant.
참고문헌 (20)
- Polak M, "Hyperthyroidism in early infancy : pathogenesis, clinical features and diagnosis with a focus on neonatal hyperthyroidism", Thyroid, 8, pp.1171~1177 (1998)
- Fuhrer D, "Novel TSHR germline mutation (Met463Val) masquerading as Graves' disease in a large Welsh kindred with hyperthyroidism", Thyroid, 10, pp.1035~1041 (2000)
- 조원경, "Nonautoimmune congenital hyperthyroidism due to p.Asp633Glu mutation in the TSHR gene", Annals of Pediatric Endocrinology & Metabolism, 23(4), pp.235~239 (2018), 대한소아내분비학회
- Ferraz C, "Inheritable and sporadic nonautoimmune hyperthyroidism", Best Pract Res Clin Endocrinol Metab, 31, pp.265~275 (2017)
- Seo GH, "High diagnostic yield and clinical utility of WES for patients with undiagnosed genetic disorder by automating variant interpretation", bioRxiv 2019:628438, ~ (2019)
- "Genome Aggregation Database (gnomAD)"[URL]
- Ioannidis NM, "REVEL : an ensemble method for predicting the pathogenicity of rare missense variants", Am J Hum Genet, 99, pp.877~885 (2016)
- "Clinvar-NCBI"[URL]
- Richards S, "Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology", Genet Med, 17, pp.405~424 (2015)
- 김재현, "형제에서 발생한 갑상선 자극호르몬 수용체 유전자 돌연변이에 의한 갑상선 항진증 2례", Clinical and Experimental Pediatrics, 48(3), pp.337~341 (2005), 대한소아청소년과학회
- Gozu HI, "Similar prevalence of somatic TSH receptor and Gsalpha mutations in toxic thyroid nodules in geographical regions with different iodine supply in Turkey", Eur J Endocrinol, 155, pp.535~545 (2006)
- Hebrant A, "Genetic hyperthyroidism : hyperthyroidism due to activating TSHR mutations", Eur J Endocrinol, 164, pp.1~9 (2011)
- Lueblinghoff J, "Shared sporadic and somatic thyrotropin receptor mutations display more active in vitro activities than familial thyrotropin receptor mutations", Thyroid, 21, pp.221~229 (2011)
- Matsuura N, "TSH-receptor antibodies in mothers with Graves'disease and outcome in their offspring", Lancet, 1, pp.14~17 (1988)
- Tamaki H, "Prediction of later development of thyrotoxicosis or central hypothyroidism from the cord serum thyroidstimulating hormone level in neonates born to mothers with Graves disease", J Pediatr, 115, pp.318~321 (1989)
- Thomas JL, "Familial hyperthyroidism without evidence of autoimmunity", Acta Endocrinologica, 100, pp.512~518 (1982)
- Duprez L, "Germline mutations in the thyrotropin receptor gene cause non-autoimmune autosomal dominant hyperthyroidism", Nat Genet, 7, pp.396~401 (1994)
- Karges B, "TSH receptor mutation V509A causes familial hyperthyroidism by release of interhelical constraints between transmembrane helices TMH3 and TMH5", J Endocrinol, 186, pp.377~385 (2005)
- Fuhrer D, "Identification of a new thyrotropin receptor germline mutation (Leu629Phe) in a family with neonatal onset of autosomal dominant nonautoimmune hyperthyroidism", J Clin Endocrinol Metab, 82, pp.4234~4238 (1997)
- Rivkees SA, "Clinical review 99: the management of Graves' disease in children, with special emphasis on radioiodine treatment", J Clin Endocrinol Metab, 83, pp.3767~3776 (1998)